viewSaga Group

Superdry gets small bonus as Saga hires former boss

Sutherland received a pay-off of £730,000 when he walked away from Superdry, but the contract stipulated the amount will decrease if he found another job within a year

Saga Group - F
Euan Sutherland

Saga PLC (LON:SAGA) has appointed former Superdry (LON:SDRY) boss Euan Sutherland as its new chief executive, ahead of Lance Batchelor’s retirement.

Sutherland will take up the role on 6 January, said the FTSE 250 group in a statement on Wednesday.

He quit as chief executive of fashion brand Superdry in August when co-founder Julian Dunkerton wrestled his way back onto the board, with his many complaints including that Sutherland had been paid not far off £10mln over his five years in charge while slashing 200 jobs in an effort to make £20mln cost savings.

Sutherland received a year's salary of almost £730,000 as a pay-off when he walked away from Superdry, but the contract stipulated the amount will decrease if he found another job within a year.

Previously, he has been chief executive at the Co-op Group and chief operating officer and UK chief executive at B&Q owner Kingfisher plc (LON:KGF), as well as having worked at Mars and Coca-Cola earlier in his career.

Meanwhile, Batchelor will retire after six years at the helm of the over-50s focused company, which deals in travel and insurance, continuing as a statutory director until he leaves the business on 31 January.

Batchelor led Saga’s flotation in 2014, but the last twelve months has been a tumultuous period for the group that saw it post a big loss, slash its dividend and issue a profit warning about its insurance business for this year.

Saga's shares have lost around three-quarters of their value accordingly in just over two years, leading the group to launch a new insurance strategy in April, as well as reportedly considering a potential sale of its domiciliary care business.

Quick facts: Saga Group

Price: 46.9 GBX

Market: LSE
Market Cap: £526.22 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

2 days, 2 hours ago

2 min read